Pinned post
In Japan, the must-see attractions aren't just temples and landmarks. They're convenience stores, high-tech toilets and trains. But as everyday Japan draws crowds, pressure on local communities and businesses grows. 👉 ebx.sh/L2zaLJ
The Japan Times
Verified account This account is verified. Learn more@japantimes
Breaking news and features about Japan from the nation's most widely read English-language newspaper.
日本で最も読まれている英文ニュース。
More: jtim.es/m/social
日本で最も読まれている英文ニュース。
More: jtim.es/m/social
32 Following 483K Followers 344K Posts
Latest posts 5
A western intelligence estimate says Iran can build about 50 ballistic missiles per month — roughly half its prewar capacity — providing a means of retaliation if hostilities resume, despite months of airstrikes. ebx.sh/Oo81FB
ebx.sh Iran producing 50 missiles per month despite crippled industry The U.S. has said since the early days of the war that Tehran’s arsenal, and its ability to reconstitute it, had been thoroughly degraded. Onosato looks sharp, Fujiryoga has already claimed a gold star and even some wrestlers with losing records are performing well as the Fukuoka basho takes shape. ebx.sh/xnqEsv
ebx.sh Onosato looks sharp as Kyushu Basho contenders emerge Three days is too early to draw firm conclusions, but Onosato, Fujiryoga Tamawashi and others have impressed. Opposition lawmakers pressed Prime Minister Sanae Takaichi on how much people would save and who would qualify for income-linked cash payments as debate in the Upper House began on a bill to cut the food consumption tax. ebx.sh/qfa2FT
ebx.sh Opposition presses for consumption tax cut details as Upper House debate begins While questioning actual savings and who would qualify for cash payments, lawmakers asked how households would fare after the tax cut expires. A Japanese research team has identified a cell-surface receptor protein that binds to the rubella virus and allows it to enter human airways and placental cells. ebx.sh/J8AkVb
ebx.sh Japan research team identifies rubella virus receptor Although vaccines for rubella are widely available, identifying the main receptor for the virus may aid the development of antiviral drugs.